Benzoyl Peroxide Microcapsules for Controlled Rosacea Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for rosacea, particularly those involving benzoyl peroxide, often cause irritation and intolerance issues due to rapid dissolution, and are only suppressive, failing to provide long-term, curative solutions for the chronic nature of the condition.
Innovation Solution
A topical composition with benzoyl peroxide in a solid form, formulated to have a controlled dissolution rate of less than 80% per hour, which can include additional active agents like antibiotics or retinoids, encapsulated in microcapsules to ensure a slow and prolonged release, reducing adverse effects and improving treatment efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If benzoyl peroxide is used in conventional formulations, then rosacea symptoms are suppressed, but irritation and intolerance occur due to rapid dissolution
Solution Approach 1:
The patent changes the dissolution rate parameter of benzoyl peroxide from rapid to controlled slow dissolution (less than 80% per hour), transforming it from a harmful fast-acting substance to a beneficial slow-release treatment that maintains efficacy while reducing irritation and intolerance
Solution Approach 2:
The patent uses microcapsules with controlled permeability membranes to encapsulate benzoyl peroxide, creating a flexible shell structure that controls the release rate and protects the skin from direct exposure to high concentrations of the active ingredient
2Duration of action of moving object
If conventional rosacea treatments are used, then symptomatic relief is achieved, but long-term curative solution is not provided due to suppressive nature
Solution Approach 1:
The patent implements continuous controlled release of benzoyl peroxide over extended periods through microencapsulation, ensuring sustained therapeutic action that addresses both short-term symptom relief and long-term curative needs without interruption or loss of efficacy
3Speed
If benzoyl peroxide dissolves rapidly, then immediate therapeutic effect is achieved, but adverse effects increase
Solution Approach 1:
The patent fundamentally changes the dissolution rate parameter from fast to slow (controlled at less than 80% per hour), transforming the speed characteristic to reduce adverse events while preserving therapeutic benefit through prolonged exposure
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The controlled release composition provides safer and more effective treatment of rosacea symptoms with reduced adverse events, achieving comparable results to compositions with antibacterial agents while minimizing irritation and intolerance, and demonstrating significant improvement in Investigator Global Assessment scores.
Implementation Method 1
encapsulated in microcapsules to ensure a slow and prolonged release
Implementation Method 2
dissolution rate of the benzoyl peroxide from composition is less than about 80% weight/h
Data Source
AI summary
The present invention relates to pharmaceutical compositions for topical use (including also dermatological compositions), for treating skin conditions and afflictions, such as rosacea and symptoms and conditions associated there from.